News
Profusa
PFSA · NASDAQ
$0.885−$0.0152 (−1.69%)TodayMarket closed ·
Prev close $0.9002
Latest news
- Press releaseGlobe Newswire
Profusa Receives ISO 13485:2016 Certificate from GMED
- NewsVandana Singh
Micro Cap Profusa Navigates European Regulatory Hurdles to Advance Oxygen Monitoring Tech
- Press releaseGlobe Newswire
Here’s What Investors Are Watching, Including $20 Price Target Bombshell
- NewsAvi Kapoor
Dow Tumbles Over 100 Points; US Jobless Claims Fall to 197,000
- News
12 Health Care Stocks Moving In Wednesday's Intraday Session
- News
12 Health Care Stocks Moving In Tuesday's After-Market Session
- News
12 Health Care Stocks Moving In Tuesday's Intraday Session
- News
12 Health Care Stocks Moving In Monday's Intraday Session
- News
12 Health Care Stocks Moving In Friday's Intraday Session
- News
12 Health Care Stocks Moving In Friday's Pre-Market Session
- News
12 Health Care Stocks Moving In Thursday's After-Market Session
- News
12 Health Care Stocks Moving In Thursday's Intraday Session
- NewsAvi Kapoor
Dow Gains Over 100 Points; Target Posts Upbeat Q2 Earnings
- NewsAvi Kapoor
Mercury Systems Posts Mixed Q4 Results, Joins WhiteFiber And Other Big Stocks Moving Lower In Wednesday’s Pre-Market Session
- NewsMohd Haider
Profusa Stock Dips After Hours As Whopping 506% Rally Cools: Here Is Why PFSA Is Trending
- NewsShivdeep Dhaliwal
Profusa, Baidu, Amylyx Pharmaceuticals, FreeCast and Klarna Group: Why These 5 Stocks Are on Investors' Radars Today
- NewsAvi Kapoor
Nasdaq Down Over 1%; Home Depot Earnings Top Estimates
- NewsAkanksha Bakshi
Why Is Profusa Stock Falling Monday?
- Press releaseGlobe Newswire
Profusa Submits Response Package to GMED as Part of Ongoing CE Mark Review Process for Lumee® Oxygen Platform
- Press releaseGlobe Newswire
Former Trump Administration VA Secretary Peter O'Rourke Sr. Joins Quantum Cyber's Board of Directors
- News
Profusa Initiates Board-Led Process To Evaluate Strategic Alternatives Intended To Maximize Shareholder Value And Support Commercial, Regulatory And Platform-Expansion Initiatives
- Press releaseGlobe Newswire
Profusa Initiates Board-Led Process to Evaluate Strategic Alternatives and Maximize Shareholder Value
- NewsAvi Kapoor
Crude Oil Gains 3%; Alignment Healthcare Shares Jump
- NewsAvi Kapoor
Dow Falls 200 Points; US Durable Goods Orders Decline In February
- NewsAvi Kapoor
Gold Edges Higher; ISM Services PMI Falls In March
- NewsAvi Kapoor
US Stocks Mixed; Nasdaq Gains Over 100 Points
- News
Market-Moving News for April 6th
- News
12 Health Care Stocks Moving In Thursday's Intraday Session
- News
12 Health Care Stocks Moving In Thursday's Pre-Market Session
- News
12 Health Care Stocks Moving In Tuesday's After-Market Session
- News
12 Health Care Stocks Moving In Thursday's Intraday Session
- News
12 Health Care Stocks Moving In Thursday's Pre-Market Session
- News
12 Health Care Stocks Moving In Thursday's After-Market Session
- News
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
- NewsAvi Kapoor
Why FuelCell Energy Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
- NewsAvi Kapoor
Why Vanda Pharmaceuticals Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket
- NewsShivdeep Dhaliwal
Nio, Profusa, Nike, FTAI Aviation And Under Armour: Why These 5 Stocks Are On Investors' Radars Today
- NewsAvi Kapoor
Why OceanFirst Financial Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
- NewsAvi Kapoor
US Stocks Lower; Home Price Growth Eases in October
- Press releasePRNewswire
Report Highlights Growth in AI Biomarker Monitoring as Industry Giant's GPUs Power Next-Gen Platform
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.